ASASANTIN RETARD 200/25 mg/mg Capsules Modified Release Írsko - angličtina - HPRA (Health Products Regulatory Authority)

asasantin retard 200/25 mg/mg capsules modified release

boehringer ingelheim limited - dipyridamole, acetylsalicylic acid - capsules modified release - 200/25 mg/mg - platelet aggregation inhibitors excl. heparin

Phyllocontin Continus 225 mg Prolonged Release Tablets Írsko - angličtina - HPRA (Health Products Regulatory Authority)

phyllocontin continus 225 mg prolonged release tablets

mundipharma pharmaceuticals limited - aminophylline hydrate - prolonged-release tablet - 225 milligram(s) - xanthines; aminophylline

PRIFTIN TABLET Južná Afrika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

priftin tablet

sanofi-aventis south africa (pty) ltd - tablet - see ingredients - each tablet contains rifapentine 150,0 mg

Phyllocontin Continus 225 mg Prolonged Release Tablets Írsko - angličtina - HPRA (Health Products Regulatory Authority)

phyllocontin continus 225 mg prolonged release tablets

ennogen healthcare (europe) limited - aminophylline hydrate - prolonged-release tablet - xanthines; aminophylline

Prolastin 4000 mg, powder and solvent for solution for infusion Írsko - angličtina - HPRA (Health Products Regulatory Authority)

prolastin 4000 mg, powder and solvent for solution for infusion

grifols deutschland gmbh - human alpha1-proteinase inhibitor - powder and solvent for solution for infusion - alfa1 antitrypsin

Prolastin 5000 mg, powder and solvent for solution for infusion Írsko - angličtina - HPRA (Health Products Regulatory Authority)

prolastin 5000 mg, powder and solvent for solution for infusion

grifols deutschland gmbh - human alpha1-proteinase inhibitor - powder and solvent for solution for infusion - alfa1 antitrypsin